The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis
Condition(s):Pancreatitis; Cholangiopancreatography, Endoscopic Retrograde; IndomethacinLast Updated:March 15, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Pancreatitis; Cholangiopancreatography, Endoscopic Retrograde; IndomethacinLast Updated:March 15, 2024Completed
Condition(s):Post-ERCP Acute PancreatitisLast Updated:June 28, 2023Recruiting
Condition(s):Acute Pancreatitis; Systemic Inflammatory Response SyndromeLast Updated:February 17, 2023Recruiting
Condition(s):Patent Ductus Arteriosus After Premature BirthLast Updated:October 6, 2021Withdrawn
Condition(s):Difficult Embryo TransferLast Updated:December 30, 2015Unknown status
Condition(s):Pain, PostoperativeLast Updated:January 26, 2018Completed
Condition(s):Post-ERCP Acute PancreatitisLast Updated:June 29, 2016Completed
Condition(s):Post ERCP Acute PancreatitisLast Updated:March 24, 2015Completed
Condition(s):Post ERCP PancreatitisLast Updated:December 15, 2023Recruiting
Condition(s):Patent Ductus ArteriosusLast Updated:December 3, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.